- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06144125
Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery
November 16, 2023 updated by: Tae-Yop Kim, MD PhD, Konkuk University Medical Center
Prothrombin Complex Concentrate and Fresh Frozen Plasma in Viscoelastic Test-based Goal-directed Bleeding Management in Cardiac Surgery
The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
152
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tae-Yop Kim, MD PhD
- Phone Number: +82-10-8811-6942
- Email: taeyop@gmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- patients undergoing cardiac surgery
Exclusion Criteria:
- thrombocytopenia
- oral anti-coagulant
- anti platelet agents
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: fresh frozen plasma
according to the Rotational thromboelastometry (ROTEM) test, CT-EXTEM prolongation, fresh frozen plasma transfusion (FFP) is performed
|
transfusion of fresh frozen plasma
|
Experimental: prothrombin complex concentrate
according to the Rotational thromboelastometry (ROTEM) test, CT-EXTEM prolongation, prothrombin complex concentrate (PCC) is administered
|
prothrombin complex concentrate administration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
treatment time
Time Frame: 1 min
|
duration from the time diagnosing CT-EXTEM prolongation to the time achieving bleeding control
|
1 min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Red Blood Cell amount
Time Frame: I hour
|
Red Blood Cell transfusion amount during surgery
|
I hour
|
FFP amount
Time Frame: 1 hour
|
Red Blood Cell transfusion amount during surgery
|
1 hour
|
Platelet amount
Time Frame: 1 hour
|
Platelet transfusion amount during surgery
|
1 hour
|
CT-EXTEM
Time Frame: 10 min
|
clotting time-EXTEM after PCC or FFP
|
10 min
|
MA-EXTEM
Time Frame: 10 min
|
Maximal amplitude-EXTEM after PCC or FFP
|
10 min
|
MA-FIBTEM
Time Frame: 10 min
|
Maximal amplitude-FIBTEM after PCC or FFP
|
10 min
|
Postoperative bleeding
Time Frame: 24 hour
|
chest tube drainage at postoperative 24 hour
|
24 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tae-Yop Kim, MD PhD, Konkuk University Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 1, 2024
Primary Completion (Estimated)
April 1, 2025
Study Completion (Estimated)
April 1, 2025
Study Registration Dates
First Submitted
November 16, 2023
First Submitted That Met QC Criteria
November 16, 2023
First Posted (Estimated)
November 22, 2023
Study Record Updates
Last Update Posted (Estimated)
November 22, 2023
Last Update Submitted That Met QC Criteria
November 16, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HC22195220002004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Valve Disease
-
University of British ColumbiaRecruitingSurgery | Cardiac Event | Cardiac Disease | Cardiac Complication | Cardiac Valve Disease | Surgery-ComplicationsCanada
-
Centre Chirurgical Marie LannelongueCompletedCardiac Catheterization | Cardiac Valve Disease | Paravalvular Aortic Regurgitation | Paravalvular Mitral Regurgitation
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingAortic Valve Disease | Cardiac Valve Disease | Mitral Valve Disease | Tricuspid Valve DiseaseNetherlands
-
Astana Medical UniversityCompletedMitral Valve Insufficiency | Aortic Valve Insufficiency | Cardiac DiseaseKazakhstan
-
University of TurkuBrigham and Women's HospitalActive, not recruitingCoronary Artery Disease | Atrial Fibrillation | Aortic Valve Stenosis | Aortic Valve Disease | Cardiac Surgery | Cardiac Arrythmias | Mitral Valve Disease | Cardiac TumorFinland
-
Beth Israel Deaconess Medical CenterRecruitingAortic Stenosis | Heart Block | Transcatheter Aortic Valve ReplacementUnited States
-
University Medical Centre MariborRecruitingCardiac Disease | Cardiac Valve DiseaseSlovenia
-
Rambam Health Care CampusUnknownDegenerative Cardiac Valve Disease | Coronary Artery Bypass Surgery PatientsIsrael
-
Universidade Metodista de PiracicabaCompletedCardiac Valve DiseaseBrazil
-
Corcym S.r.lRecruitingCardiac Valve DiseaseUnited States, Belgium, Korea, Republic of, Germany, Italy, Switzerland, United Kingdom, France, Austria, Canada, Netherlands, Portugal, Serbia
Clinical Trials on fresh frozen plasma
-
Rigshospitalet, DenmarkUnknownSurgery | Ischemic Reperfusion Injury | Abdominal Aortic AneurismDenmark
-
Xinqiao Hospital of ChongqingUnknown
-
Duke UniversityCompletedExtracorporeal Membrane OxygenationUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Rutgers, The State University of New JerseyJohns Hopkins University; National Heart, Lung, and Blood Institute (NHLBI); University... and other collaboratorsCompletedHemorrhage | Blood Coagulation DisordersUnited States
-
Mayo ClinicCompletedSurgical Procedures, Minimally Invasive | Blood Coagulation, DisordersUnited States
-
Ain Shams UniversityRecruiting
-
University of ZurichCompleted
-
HemCon Medical Technologies, IncCompleted
-
Montefiore Medical CenterWithdrawnLiver Cirrhosis | Ascites Hepatic